The FDA has given final approval for a generic version of Requip (ropinirole hydrochloride) used to treat Restless Leg Syndrome. The portion of the patent that covers the same drug for Parkinson's Disease doesn't expire for another month. It's expected that companies will apply for approval to label it for treatment of Parkinson's once that patent expires.
If interested, you can view the details at http://www.fda.gov/bbs/topics/NEWS/2008/NEW01832.html
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment